Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.
Public ClinicalTrials.gov record NCT03856047. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Investigation of Safety and Efficacy of NNC0174-0833 for Weight Management - a Dose Finding Trial.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will look at the change in body weight in people taking NNC0174-0833, liraglutide and "dummy" medicine, from the start to the end of the study. As well as taking the medicine, participants will have talks with study staff about healthy food choices, how to be more physically active and what participants can do to lose weight. Participants will either take NNC0174-0833, liraglutide or "dummy" medicine - which treatment participants get is decided by chance. Participants will need to take one injection once a week or once a day, depending on the treatment. The study medicine is injected with a thin needle in a skin fold in the stomach, thigh or upper arm. The study will last for about 8 months. Participants will have 12 clinic visits with the study doctor.
Study identification
- NCT ID
- NCT03856047
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 706 participants
Conditions and interventions
Conditions
Interventions
- NNC0174-0833 Drug
- Placebo (NNC0174-0833) Drug
- Liraglutide 3.0 mg Drug
- Placebo (Liraglutide 3.0 mg) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 1, 2019 (Actual)
- Primary completion
- Mar 2, 2020 (Actual)
- Completion
- Mar 25, 2021 (Actual)
- Last update posted
- Jul 5, 2024
2019 – 2021
United States locations
- U.S. sites
- 22
- U.S. states
- 13
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Anaheim Clinical Trials, LLC | Anaheim | California | 92801 | — |
| Encompass Clinical Research | Spring Valley | California | 91978 | — |
| Nature Coast Clinical Research | Crystal River | Florida | 34429 | — |
| Jacksonville Center For Clinical Research | Jacksonville | Florida | 32216 | — |
| South Broward Research LLC | Pembroke Pines | Florida | 33027 | — |
| St Johns Center For Clinical Research | Ponte Vedra | Florida | 32081 | — |
| Cedar-Crosse Research Center | Chicago | Illinois | 60607 | — |
| Centennial Medical Group | Elkridge | Maryland | 21075-6437 | — |
| Infinity Medical Research | North Dartmouth | Massachusetts | 02747 | — |
| Rochester Clinical Research, Inc. | Rochester | New York | 14609 | — |
| PharmQuest | Greensboro | North Carolina | 27408 | — |
| Prestige Clinical Research | Franklin | Ohio | 45005 | — |
| Albert J Weisbrot | Mason | Ohio | 45040-6815 | — |
| Family Practice Center of Wadsworth, Inc. | Wadsworth | Ohio | 44281 | — |
| Lynn Institute of Norman | Norman | Oklahoma | 73069 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Spectrum Medical Research, LLC | Gaffney | South Carolina | 29341 | — |
| Spartanburg Medical Research | Spartanburg | South Carolina | 29303 | — |
| Holston Medical Group Pc | Bristol | Tennessee | 37620-7352 | — |
| Texas Diabetes & Endocinology | Round Rock | Texas | 78681 | — |
| Washington Center For Weight Management And Research,Inc. | Arlington | Virginia | 22206 | — |
| National Clinical Research Inc. | Richmond | Virginia | 23294 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03856047, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 5, 2024 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03856047 live on ClinicalTrials.gov.